Skip to main content
OpenTrials

Clinical trial condition

Advanced Solid Tumor

Explore clinical trials studying Advanced Solid Tumor. Study availability and eligibility vary by location and protocol.

514 public trials 240 recruiting studies
Refine in advanced search Browse all conditions

Advanced Solid Tumor trial results

Completed

Study of PCLX-001 in R/R Advanced Solid Malignancies and B-cell Lymphoma

NCT04836195

Conditions
Advanced Solid Tumor, B-cell Non Hodgkin Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • BC Cancer - Vancouver Vancouver, British Columbia, Canada
  • Princess Margaret Hospital Toronto, Ontario, Canada
  • CR Centre Hospitalier de l'Université de Montréal - CHUM Montreal, Quebec, Canada
View Trial Details
Completed

A Multiple Ascending Dose Study of Milademetan in Subjects With Advanced Solid Tumors or Lymphomas

NCT01877382

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +6 more
Locations
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Columbia University College of Physicians and Surgeons New York, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Tennessee Oncology Nashville, Tennessee, United States
View Trial Details
Completed

A Study of Etigilimab and Nivolumab in Participants With Locally Advanced or Metastatic Tumors

NCT04761198

Conditions
Advanced Solid Tumor, Metastatic Solid Tumor, Neoplasm Metastasis, +5 more
Locations
  • Mereo Investigator Site Phoenix, Arizona, United States
  • Mereo Investigator Site Greenbrae, California, United States
  • Mereo Investigator Site Los Angeles, California, United States
  • Mereo Investigator Site Jacksonville, Florida, United States
View all 16 locations
View Trial Details
Completed

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901

NCT04805307

Conditions
Advanced Solid Tumor, Digestive System Diseases, Digestive System Neoplasms, +8 more
Locations
  • Sun Yat-sen University Cancer Center (SYSUCC) Guangzhou, Guangdong, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • West China Hospital of Sichuan University Chengdu, Sichuan, China
  • Affiliated Hospital of Hebei University Baoding, China
View all 32 locations
View Trial Details

Related conditions